Reintroduction Of PATA Could Improve Patient Access To Life-saving Drugs
Reintroduction of PATA could improve patient access to life-saving drugs
June 24, 2017
The American College of Rheumatology (ACR) today applauded the leadership of Rep. David McKinley (R-WV) and Rep. G.K. Butterfield (D-NC) in reintroducing H.R. 2999, the Patients’ Access to Treatment Act (PATA). The bipartisan legislation would limit cost-sharing requirements for medications placed on specialty insurance tiers and make innovative and necessary therapies more accessible to Americans living with rheumatic diseases by reducing excessive out-of-pocket expenses.
“The ACR applauds the reintroduction of the Patients’ Access to Treatment Act and the bipartisan effort by Rep. David McKinley and Rep. G.K. Butterfield to make biologic therapies more accessible and affordable for …